CIK: 0001600175
申告総資産額
$5533.8万
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IBB | Ishares Biotechnology ETF | ETF-テック型 | 44.57% | +3.86% | — | |
| 2 | LABUUSD | Drx Dly S&p Biotech Bull 3x | ETF-テック型 | 5.01% | -1.73% | — | |
| 3 | ✓ | Proqr Thrapeutics N V | 株式-その他 | 4.81% | -0.42% | — | |
| 4 | MTD | Mettler-toledo International | 株式-ヘルスケア | 4.03% | +0.10% | — | |
| 5 | ILMN | Illumina INC | 株式-ヘルスケア | 3.24% | +0.04% | -1.29% | |
| 6 | VRTX | Vertex Pharmaceuticals INC | 株式-ヘルスケア | 3.16% | +0.32% | -0.72% | |
| 7 | IONS | Ionis Pharmaceuticals INC | 株式-ヘルスケア | 2.65% | +0.27% | -4.23% | |
| 8 | QGEN | Qiagen N.V. | 株式-ヘルスケア | 2.39% | -0.01% | -0.50% | |
| 9 | SGENEUR | Seagen INC | 株式-その他 | 2.39% | +0.95% | -0.83% | |
| 10 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 2.29% | +0.56% | +5.60% | |
| 11 | ALXN | Alexion Pharmaceuticals INC | 株式-その他 | 2.25% | -0.16% | -18.37% | |
| 12 | REGN | Regeneron Pharmaceuticals | 株式-ヘルスケア | 2.07% | — | -0.59% | |
| 13 | ✓ | Loxo Oncology INC | 株式-その他 | 1.91% | — | — | |
| 14 | BMRN | Biomarin Pharmaceutical INC | 株式-ヘルスケア | 1.82% | -0.01% | -1.58% | |
| 15 | INCY | Incyte CORP | 株式-ヘルスケア | 1.71% | +0.10% | -1.13% | |
| 16 | CELG | Celgene CORP | 株式-その他 | 1.41% | +0.24% | +2.42% | |
| 17 | PCRX | Pacira Biosciences INC | 株式-その他 | 1.07% | -0.72% | EXIT | |
| 18 | NKTREUR | Nektar Therapeutics | 株式-その他 | 0.96% | -0.24% | +12.03% | |
| 19 | EXEL | Exelixis INC | 株式-ヘルスケア | 0.94% | — | +31.39% | |
| 20 | ICPTUSD | Intercept Pharmaceuticals In | 株式-その他 | 0.78% | -0.22% | -11.61% | |
| 21 | AMGN | Amgen INC | 株式-ヘルスケア | 0.72% | — | -8.47% | |
| 22 | BIIB | Biogen INC | 株式-ヘルスケア | 0.70% | — | +2.91% | |
| 23 | GRFS | Grifols Sa-adr | 株式-その他 | 0.69% | — | +4.45% | |
| 24 | FGENEUR | Fibrogen INC | 株式-その他 | 0.68% | — | -60.96% | |
| 25 | IQV | Iqvia Holdings INC | 株式-ヘルスケア | 0.68% | — | -16.25% | |
| 26 | CRL | Charles River Laboratories | 株式-ヘルスケア | 0.66% | — | -5.70% | |
| 27 | UTHR | United Therapeutics CORP | 株式-ヘルスケア | 0.64% | +0.50% | NEW | |
| 28 | GILD | Gilead Sciences INC | 株式-ヘルスケア | 0.64% | — | +1.88% | |
| 29 | ✓ | 株式-その他 | 0.60% | -1.10% | EXIT | ||
| 30 | TECH | Bio-techne CORP | 株式-ヘルスケア | 0.56% | — | -21.41% | |
| 31 | ACAD | Acadia Pharmaceuticals INC | 株式-ヘルスケア | 0.53% | +0.31% | -28.47% | |
| 32 | AGIO | Agios Pharmaceuticals INC | 株式-その他 | 0.52% | -0.36% | EXIT | |
| 33 | RARE | Ultragenyx Pharmaceutical In | 株式-その他 | 0.51% | -0.09% | -12.96% | |
| 34 | ALKS | Alkermes plc | 株式-ヘルスケア | 0.49% | +0.41% | NEW | |
| 35 | NBIX | Neurocrine Biosciences INC | 株式-ヘルスケア | 0.47% | — | -11.94% | |
| 36 | CKPTUSD | Checkpoint Therapeutics INC | 株式-その他 | 0.45% | — | — | |
| 37 | ✓ | 株式-その他 | 0.44% | +1.04% | — | ||
| 38 | XONUSD | Intrexon CORP | 株式-その他 | 0.39% | — | +14.00% | |
| 39 | RAH | Societal Cdmo INC | 株式-その他 | 0.18% | — | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | EXEL | Exelixis INC | +0.2% | +31.39% | 増加 |
| 2 | RAH | Societal Cdmo INC | 0% | — | 変化なし |
| 3 | ✓ | -0.1% | +40.57% | 増加 | |
| 4 | GRFS | Grifols Sa-adr | -0.2% | +4.45% | 増加 |
| 5 | BIIB | Biogen INC | -0.2% | +2.91% | 増加 |
| 6 | AMGN | Amgen INC | -0.2% | -8.47% | 減少 |
| 7 | GILD | Gilead Sciences INC | -0.2% | +1.88% | 増加 |
| 8 | UTHR | United Therapeutics CORP | -0.2% | -5.03% | 減少 |
| 9 | IONS | Ionis Pharmaceuticals INC | -0.2% | -4.23% | 減少 |
| 10 | CRL | Charles River Laboratories | -0.3% | -5.70% | 減少 |
| 11 | PCRX | Pacira Biosciences INC | -0.3% | — | 変化なし |
| 12 | IQV | Iqvia Holdings INC | -0.3% | -16.25% | 減少 |
| 13 | INCY | Incyte CORP | -0.3% | -1.13% | 減少 |
| 14 | REGN | Regeneron Pharmaceuticals | -0.4% | -0.59% | 減少 |
| 15 | ICPTUSD | Intercept Pharmaceuticals In | -0.4% | -11.61% | 減少 |
| 16 | ✓ | -0.5% | — | 変化なし | |
| 17 | BMRN | Biomarin Pharmaceutical INC | -0.5% | -1.58% | 減少 |
| 18 | QGEN | Qiagen N.V. | -0.5% | -0.50% | 減少 |
| 19 | ACAD | Acadia Pharmaceuticals INC | -0.5% | -28.47% | 減少 |
| 20 | CKPTUSD | Checkpoint Therapeutics INC | -0.5% | — | 変化なし |
| 21 | NBIX | Neurocrine Biosciences INC | -0.5% | -11.94% | 減少 |
| 22 | TECH | Bio-techne CORP | -0.5% | -21.41% | 減少 |
| 23 | ALNY | Alnylam Pharmaceuticals INC | -0.5% | +5.60% | 増加 |
| 24 | XONUSD | Intrexon CORP | -0.6% | +14.00% | 増加 |
| 25 | RARE | Ultragenyx Pharmaceutical In | -0.6% | -12.96% | 減少 |
| 26 | ✓ | Loxo Oncology INC | -0.6% | — | 変化なし |
| 27 | CELG | Celgene CORP | -0.7% | +2.42% | 増加 |
| 28 | MTD | Mettler-toledo International | -0.7% | — | 変化なし |
| 29 | NKTREUR | Nektar Therapeutics | -0.8% | +12.03% | 増加 |
| 30 | VRTX | Vertex Pharmaceuticals INC | -0.9% | -0.72% | 減少 |
| 31 | ILMN | Illumina INC | -1.1% | -1.29% | 減少 |
| 32 | SGENEUR | Seagen INC | -1.2% | -0.83% | 減少 |
| 33 | ✓ | Proqr Thrapeutics N V | -1.6% | — | 変化なし |
| 34 | FGENEUR | Fibrogen INC | -1.8% | -60.96% | 減少 |
| 35 | ALXN | Alexion Pharmaceuticals INC | -2% | -18.37% | 減少 |
| 36 | ALKS | Alkermes plc | -2.1% | -69.87% | 減少 |
| 37 | AGIO | Agios Pharmaceuticals INC | -2.3% | -66.13% | 減少 |
| 38 | IBB | Ishares Biotechnology ETF | — | NEW | 新規購入 |
| 39 | T8S | Tesaro INC | — | EXIT | 全売却 |
| 40 | CLVSEUR | Clovis Oncology INC | — | EXIT | 全売却 |
| 41 | LABUUSD | Drx Dly S&p Biotech Bull 3x | — | NEW | 新規購入 |
| 42 | MEIPUSD | Lite Strategy INC | — | EXIT | 全売却 |
| 43 | ACHNEUR | Achillion Pharmaceuticals | — | EXIT | 全売却 |
| 44 | ADMSEUR | Adamas Pharmaceuticals INC | — | EXIT | 全売却 |
| 45 | AXSM | Axsome Therapeutics INC | — | EXIT | 全売却 |
| 46 | AKBA | Akebia Therapeutics INC | — | EXIT | 全売却 |
| 47 | PRTKEUR | Paratek Pharmaceuticals INC | — | EXIT | 全売却 |
| 48 | CFRXEUR | Contrafect CORP | — | EXIT | 全売却 |
| 49 | ✓ | Scynexis INC Com New | — | EXIT | 全売却 |